Hypofractionated radiotherapy for the palliation of patients with advanced head and neck cancer who are unsuitable for an attempt at curative treatment

Phase 2

Completed

• Conditions: Advanced head and neck cancer; Cancer - Head and neck

• Registration Number: ACTRN12605000114640
• Lead Sponsor: Dr Sandro Porceddu

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-08-09
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Biopsy proven squamus cell carcinoma (primary or regional nodal disease) of the head and neck, ineligible for curative treatment, performance status 0-2, life expectanccy of at least 4 months, written informed consent.

Exclusion Criteria

No exclusion criteria

Study & Design

• Study Type: Interventional
• Study Design: Not specified